These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11166930)

  • 1. Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice.
    Ise Y; Katayama S; Hirano M; Aoki T; Narita M; Suzuki T
    Neurosci Lett; 2001 Feb; 299(1-2):29-32. PubMed ID: 11166930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Gβγ-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward.
    Hoot MR; Sypek EI; Reilley KJ; Carey AN; Bidlack JM; McLaughlin JP
    Behav Pharmacol; 2013 Apr; 24(2):144-52. PubMed ID: 23412114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice.
    Nozaki C; Kamei J
    Eur J Pharmacol; 2006 Dec; 552(1-3):99-104. PubMed ID: 17056034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning.
    Rafieian-Kopaei M; Gray AM; Spencer PS; Sewell RD
    Eur J Pharmacol; 1995 Mar; 275(2):185-9. PubMed ID: 7796854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluvoxamine on sufentanil antinociception and tolerance under chronic intravenous infusion in rats.
    Luger TJ; Lorenz IH; Grabner-Weiss C; Schlager A; Kolbitsch C; Keller C; Gassner M
    Pharmacol Toxicol; 1999 Dec; 85(6):263-8. PubMed ID: 10628901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.
    Mori T; Shibasaki Y; Matsumoto K; Shibasaki M; Hasegawa M; Wang E; Masukawa D; Yoshizawa K; Horie S; Suzuki T
    J Pharmacol Exp Ther; 2013 Oct; 347(1):91-9. PubMed ID: 23902939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingested placenta blocks the effect of morphine on gut transit in Long-Evans rats.
    Corpening JW; Doerr JC; Kristal MB
    Brain Res; 2004 Aug; 1016(2):217-21. PubMed ID: 15246857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between different antidepressants and morphine alter gastrointestinal transit in mice.
    Backer MM; Schreiber S; Pick CG
    Life Sci; 1997; 61(9):PL109-13. PubMed ID: 9284086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interference of dexamethasone on some morphine effects: hypothesis for the steroid-opioid interaction.
    Capasso A; Loizzo A
    Recent Pat CNS Drug Discov; 2008 Jun; 3(2):138-50. PubMed ID: 18537773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines].
    Imanishi T; Onozawa K; Hayashi A; Baba J
    Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):403-10. PubMed ID: 11778459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
    Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
    Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of TAN-452, a novel peripherally acting opioid receptor antagonist for the treatment of opioid-induced bowel syndromes.
    Suzuki T; Sawada T; Kawai K; Ishihara Y
    Life Sci; 2018 Dec; 215():246-252. PubMed ID: 30036489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective serotonin reuptake inhibitor fluvoxamine suppresses post-feeding hyperactivity induced by food restriction in rats.
    Yokoyama F; Onozawa K; Kakui N; Imanishi T
    Pharmacol Biochem Behav; 2007 May; 87(1):98-103. PubMed ID: 17493672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of morphine-induced antinociception and locomotion by citalopram is accompanied by anxiolytic-like effects.
    Varela MJ; Acanda de la Rocha AM; Díaz A; Lopez-Gimenez JF
    Pharmacol Biochem Behav; 2017 Dec; 163():83-89. PubMed ID: 29024681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abatement of morphine-induced slowing in gastrointestinal transit by Dai-kenchu-to, a traditional Japanese herbal medicine.
    Nakamura T; Sakai A; Isogami I; Noda K; Ueno K; Yano S
    Jpn J Pharmacol; 2002 Feb; 88(2):217-21. PubMed ID: 11928724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.